A 12-week multicenter, randomized, double-blind, parallel-group, active-control study to evaluate the antihypertensive efficacy and safety of an Exforge?? (valsarten/ amlodipine)-based regimen versus a losarten-based regimen in patients with Stage 2 syst
|Effective start/end date||4/6/09 → 9/30/10|
- NOVARTIS PHARMACEUTICALS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.